AAA names apoints four board members
This article was originally published in Scrip
Executive Summary
Saint-Genis-Pouilly, France-based Advanced Accelerator Applications, a specialist company developing molecular nuclear medicines, has named four industry experts to its board of directors. They are: Dr Yvonne Greenstreet, who was a senior vice-president and the head of medicines development at Pfizer from 2010 to 2013. Dr Greenstreet also currently serves on the advisory board of the Bill and Melinda Gates Foundation and as a member of the board of directors of Pacira. Also joining the board is Steve Gannon, a senior vice-president, chief financial officer and treasurer at Aptalis Pharma; Leopoldo Zambeletti, an independent strategic advisor to life science companies on Merger and Acquisitions, out-licensing deals and financing strategy; and Christian Merle, a managing partner at Merle & Partners, advisory.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.